Revisiting the effect of the Pap test on cervical cancer.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 10754980.
- Also identified by PMC identifier 1446197.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This report documents the effect of not having had a Papanicolaou (Pap) test on survival with uterine cervical squamous carcinoma. Data were derived from Charity Hospital of Louisiana at New Orleans Tumor Registry reports for 1984-1987 and 1996. During the 5 study years, 101 of 213 women (47%) with invasive carcinoma had not undergone a previous Pap test. From 1984 to 1987, the observed 5-year survival rate for 171 patients with invasive carcinoma was 43%. The observed 5-year rate for 107 patients with carcinoma in situ from 1984 to 1986 was 99%. The goal of a yearly Pap test for all women can be approached by a number of different routes, with the use of all health facilities augmented with collection of specimens by trained nonphysician personnel.
Medical subject headings
- Carcinoma in Situ
- Carcinoma, Squamous Cell
- Papanicolaou Test
- Uterine Cervical Neoplasms
- Vaginal Smears